These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 11889422)

  • 1. Survival of fetal skin grafts is prolonged on the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient mouse/skin allograft model.
    Erdag G; Morgan JR
    Transplantation; 2002 Feb; 73(4):519-28. PubMed ID: 11889422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic versus xenogeneic immune reaction to bioengineered skin grafts.
    Erdag G; Morgan JR
    Cell Transplant; 2004; 13(6):701-12. PubMed ID: 15648740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The allogeneic response to cultured human skin equivalent in the hu-PBL-SCID mouse model of skin rejection.
    Briscoe DM; Dharnidharka VR; Isaacs C; Downing G; Prosky S; Shaw P; Parenteau NL; Hardin-Young J
    Transplantation; 1999 Jun; 67(12):1590-9. PubMed ID: 10401767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermal microvascular injury in the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient (HuPBL-SCID) mouse/skin allograft model is T cell mediated and inhibited by a combination of cyclosporine and rapamycin.
    Murray AG; Schechner JS; Epperson DE; Sultan P; McNiff JM; Hughes CC; Lorber MI; Askenase PW; Pober JS
    Am J Pathol; 1998 Aug; 153(2):627-38. PubMed ID: 9708821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed rejection of fetal pig pancreas in CD4 cell deficient mice was correlated with residual helper activity.
    Zhan Y; Corbett AJ; Brady JL; Sutherland RM; Lew AM
    Xenotransplantation; 2000 Nov; 7(4):267-74. PubMed ID: 11081761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloimmune injury and rejection of human skin grafts on human peripheral blood lymphocyte-reconstituted non-obese diabetic severe combined immunodeficient beta2-microglobulin-null mice.
    Turgeon NA; Banuelos SJ; Shultz LD; Lyons BL; Iwakoshi N; Greiner DL; Mordes JP; Rossini AA; Appel MC
    Exp Biol Med (Maywood); 2003 Oct; 228(9):1096-104. PubMed ID: 14530522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic human skin graft rejection in severe combined immunodeficient mice engrafted with human PBL from an HLA-presensitized donor.
    Kawamura T; Niguma T; Fechner JH; Wolber R; Beeskau MA; Hullett DA; Sollinger HW; Burlingham WJ
    Transplantation; 1992 Mar; 53(3):659-65. PubMed ID: 1549862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The degree of phylogenetic disparity of islet grafts dictates the reliance on indirect CD4 T-cell antigen recognition for rejection.
    Rayat GR; Johnson ZA; Beilke JN; Korbutt GS; Rajotte RV; Gill RG
    Diabetes; 2003 Jun; 52(6):1433-40. PubMed ID: 12765954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monokine induced by interferon-gamma (MIG/CXCL9) is derived from both donor and recipient sources during rejection of class II major histocompatibility complex disparate skin allografts.
    Auerbach MB; Shimoda N; Amano H; Rosenblum JM; Kish DD; Farber JM; Fairchild RL
    Am J Pathol; 2009 Jun; 174(6):2172-81. PubMed ID: 19389928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged survival of fetal pig islet xenografts in mice lacking the capacity for an indirect response.
    Koulmanda M; Laufer TM; Auchincloss H; Smith RN
    Xenotransplantation; 2004 Nov; 11(6):525-30. PubMed ID: 15479462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of CD4+ and CD8+ T cells in discordant skin xenograft rejection.
    Uchida T; Tomita Y; Anzai K; Zhang QW; Yoshikawa M; Kishihara K; Nomoto K; Yasui H
    Transplantation; 1999 Dec; 68(11):1721-7. PubMed ID: 10609949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The critical role of mouse CD4+ cells in the rejection of highly disparate xenogeneic pig thymus grafts.
    Zhao Y; Swenson K; Wekerle T; Rodriguez-Barbosa JI; Arn JS; Sykes M
    Xenotransplantation; 2000 May; 7(2):129-37. PubMed ID: 10961297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of immune rejection of mouse neocortex transplanted into neonatal rat brain, and effects of host immunosuppression.
    Marion DW; Pollack IF; Lund RD
    Brain Res; 1990 Jun; 519(1-2):133-43. PubMed ID: 2397402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human leukocyte antigen-DR matching improved skin graft survival from transgenic pigs to accommodate SCID mice reconstituted with human peripheral blood mononuclear cells.
    Tu CF; Tai HC; Chen CM; Huang TT; Lee JM; Yang TS; Chen CH; Tseng YL; Chou NK; Lee PH
    Transplant Proc; 2008 Mar; 40(2):578-80. PubMed ID: 18374133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
    Qian S; Fu F; Li Y; Lu L; Rao AS; Starzl TE; Thomson AW; Fung JJ
    Immunology; 1996 May; 88(1):124-9. PubMed ID: 8707337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic antagonism of Mig inhibits cellular infiltration and promotes survival of class II MHC disparate skin allografts.
    Kobayashi H; Novick AC; Toma H; Fairchild RL
    Transplantation; 2002 Aug; 74(3):387-95. PubMed ID: 12177619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet allograft, islet xenograft, and skin allograft survival in CD8+ T lymphocyte-deficient mice.
    Desai NM; Bassiri H; Kim J; Koller BH; Smithies O; Barker CF; Naji A; Markmann JF
    Transplantation; 1993 Apr; 55(4):718-22. PubMed ID: 8475541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged skin allograft survival in Scid mice reconstituted with isogeneic bone marrow stem cell antigen-1-positive cells and thymus tissue.
    Gao Z; Tibbles L; Yilmaz S; Gao Y; MacDonald A
    Transplant Proc; 2005 Jun; 37(5):2300-2. PubMed ID: 15964404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
    Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
    Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
    Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL
    Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.